Recombinant Human Fanconi anemia group I protein (FANCI), Truncated

Cat.No	ACP10256	Target Name	FANCI
Target Synonyms	FANCI; FANCI gene; FANCI_HUMAN; Fanconi anemia group I protein; Fanconi anemia; complementation group I; FLJ10719; FLJ14658; KIAA1794; Protein FACI; Protein FANCI	Form	Lyophilized powder
Expression System	Custom Production. Please inquire and provide the desire expression system.	Protein Length	Partial
Purity	>85% (SDS-PAGE)	Storage Buffer	5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Cat.No

ACP10256

Target Name

FANCI

Target Synonyms

FANCI; FANCI gene; FANCI_HUMAN; Fanconi anemia group I protein; Fanconi anemia; complementation group I; FLJ10719; FLJ14658; KIAA1794; Protein FACI; Protein FANCI

Form

Lyophilized powder

Expression System

Custom Production. Please inquire and provide the desire expression system.

Protein Length

Partial

Purity

>85% (SDS-PAGE)

Storage Buffer

5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Target Species	Human	Uniprot ID	Q9NVI1

Background Information

Uniprot Id

Q9NVI1
Target Species

Human
Target Name

FANCI
Target Full Name

Fanconi anemia group I protein
Target Function

Plays an essential role in the repair of DNA double-strand breaks by homologous recombination and in the repair of interstrand DNA cross-links (ICLs) by promoting FANCD2 monoubiquitination by FANCL and participating in recruitment to DNA repair sites. Required for maintenance of chromosomal stability. Specifically binds branched DNA: binds both single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA). Participates in S phase and G2 phase checkpoint activation upon DNA damage.
Target Involvement

Fanconi anemia complementation group I (FANCI)
Target Subcellular Location

Nucleus. Cytoplasm. Note=Observed in spots localized in pairs on the sister chromatids of mitotic chromosome arms and not centromeres, one on each chromatids. These foci coincide with common fragile sites. They are frequently interlinked through BLM-associated ultra-fine DNA bridges.
Target Synonyms

FANCI; FANCI gene; FANCI_HUMAN; Fanconi anemia group I protein; Fanconi anemia; complementation group I; FLJ10719; FLJ14658; KIAA1794; Protein FACI; Protein FANCI
Target Background

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group I. Alternative splicing results in two transcript variants encoding different isoforms.

Recombinant Human Fanconi anemia group I protein (FANCI), Truncated

Specifications

Immunogen Information

Inquire Recombinant Human Fanconi anemia group I protein (FANCI), Truncated Now

Related Products